[Image courtesy of kwanchaift/Adobe Stock]
The year 2023 is poised to bring about an array of novel therapies that could significantly impact the treatment of several diseases. This article considers just over two dozen promising novel therapies that could generate significant sales for the industry. From hypertension to cancer, Alzheimer’s to hemophilia, these drugs could potentially change the lives of millions worldwide. 1. AprocitentanIndication: Difficult-to-treat hypertension Estimated peak sales: $2.5 billion The investigational hypertension drug aprocitentan from Idorsia Pharmaceuticals (SWX:IDIA) is a dual endothelin receptor antagonist. By blocking the peptide endothelin, the drug can block the constriction of blood vessels, thereby lowering blood pressure.
In late January, Idorsia submitted for European authorization to market aprocitentan for treatment-resistant hypertension. The compan…